This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: E27.2 (Addisonian crisis / adrenocortical insufficiency crisis) | Special Copayment Reduction: V116 (rare disease, 10% copayment for 5 years after registration) |
| B. Synonyms | Addisonian crisis, adrenocortical crisis, adrenal crisis, Acute adrenal crisis, Acute adrenocortical insufficiency, Addisonian crisis |
| C. Adult onset | Likelihood of first presentation in adulthood: high — occurs in adults with underlying adrenal insufficiency (primary or secondary) under stressful conditions such as infection, surgery, or trauma. It may also appear as the first presentation when underlying adrenal insufficiency is not known, so immediate recognition as a medical emergency is needed. |
| 1. History | 1855 first description by Addison → fatal disease before cortisone treatment → 1950s establishment of intravenous corticosteroid treatment → establishment of modern emergency protocols and patient education systems. |
| 2. Causes | Triggered by stress (infection, fever, surgery, trauma, dehydration, vomiting) in patients with underlying adrenal insufficiency (primary, secondary, tertiary); first presentation in undiagnosed adrenal insufficiency; abrupt discontinuation of glucocorticoids; bilateral adrenal hemorrhage/infarction (Waterhouse-Friderichsen). |
| 3. Genetics | No independent genotype for Addisonian crisis itself; genetic causes of underlying adrenal insufficiency (autoimmune HLA-related, AIRE deficiency, ALD, FGD genes) form the background of vulnerability to crisis. |
| 4. General epidemiology | Occurs in about 10~14/100 patient-years among patients with adrenal insufficiency; fatal crises about 0.5/100 patient-years; main precipitating factors are infection (30~40%) > surgery/procedures > trauma > others; unrecognized cases are the most dangerous. |
| 5. Pathophysiology | Stress → increased cortisol requirement → failing adrenals unable to supply → absolute or relative cortisol deficiency → vasodilation, reduced cardiac output, hypoglycemia, electrolyte imbalance → circulatory collapse and shock. |
| 6. Symptoms | Prodrome: worsening fatigue and weakness, increasing gastrointestinal symptoms; acute phase: severe abdominal pain, nausea, vomiting, sharp drop in blood pressure, hypoglycemia, decreased consciousness/coma; skin hyperpigmentation is an accompanying finding of primary adrenal insufficiency. |
| 7. Signs | Hypotension/shock; hyponatremia and hyperkalemia; hypoglycemia; fever (with underlying infection); very low cortisol; elevated ACTH (primary); possible adrenal imaging abnormalities. |
| 8. Screening | Regular education of patients with underlying adrenal insufficiency and recognition of crisis signs; emergency cortisol sampling in high-risk patients with unexplained hypotension, hypoglycemia, or hyponatremia in the emergency department; checking medical records for a history of adrenal insufficiency or steroid treatment. |
| 9. Diagnosis | Emergency serum cortisol (<18 µg/dL supports diagnosis in a crisis setting); ACTH; electrolytes, blood glucose, blood gases; blood cultures (with accompanying infection); abdominal CT (adrenal hemorrhage, etc.); do not wait for diagnosis—start treatment immediately on clinical suspicion. |
| 10. Treatment | Immediate hydrocortisone 100 mg intravenously; rapid intravenous infusion of 0.9% normal saline; correction of hypoglycemia; treatment of hyperkalemia; treatment of the precipitating cause; then tapering to a hydrocortisone maintenance dose. |
| 11. Prognosis | Near-complete recovery possible with early recognition and immediate treatment; fatal if treatment is delayed; education to prevent recurrence determines prognosis; management of the underlying disease and level of patient education are key to long-term prognosis. |
| 12. Prevention | Stress-dose education for all patients with adrenal insufficiency; always carrying emergency injection; wearing a medical alert card; adrenal crisis awareness education for medical staff; preoperative steroid coverage protocol. |
| 13. References | Rushworth RL et al. Adrenal crisis: still a life-threatening emergency … and 9 other papers |
The history of Addisonian crisis (acute adrenal crisis) is inseparably linked to the history of primary adrenocortical insufficiency (Addison disease). Among the original cases described by Thomas Addison in 1855 were patients who deteriorated rapidly and died, and from today's perspective they are judged to have been in a state of acute adrenal crisis. As descriptions of the natural history of adrenal insufficiency accumulated over the late 19th and early 20th centuries, the clinical course in which sudden extreme weakness, hypotension, nausea and vomiting, and decreased consciousness develop under conditions such as stress, infection, or trauma, leading to death within hours, began to be recognized as a syndrome.
In the era before corticosteroid treatment advanced, acute adrenal crisis was almost invariably fatal. In the 1930s, adrenal cortical extracts were shown in animal experiments and clinically to be able to reverse adrenal crisis, and after the achievements of Philip Hench and Edward Kendall, who succeeded in synthesizing cortisone, were awarded the Nobel Prize in 1950, the full era of corticosteroid treatment began. From the mid-1950s, intravenous hydrocortisone (cortisol) was established as the standard immediate treatment for acute adrenal crisis.
From the 1960s onward, as the number of patients using glucocorticoids increased sharply, secondary adrenal insufficiency and acute crisis due to abrupt discontinuation after long-term glucocorticoid use (or failure to increase the dose in stressful situations) emerged as a new clinical problem. This led to the concept of "stress dosing for steroid-dependent patients" beginning to be widely taught.
Even in modern times, acute adrenal crisis remains an important endocrine emergency, occurring at a frequency of 10~14/100 patient-years among patients with adrenal insufficiency, and fatal cases are also reported. A population-based study conducted in Germany by Hahner et al. in 2014 reported an annual adrenal crisis incidence of about 8.3/100 patient-years among patients with adrenal insufficiency, with fatal cases at about 0.5/100 patient-years, showing that the lethality of this condition has not been fully resolved even in modern medicine. In Korea, the educational materials of the Korean Endocrine Society and rare disease management guidelines treat adrenal crisis as a core item of adrenal insufficiency management, and distribution of emergency education kits for patients and awareness education for medical staff are carried out steadily.
As international attention to acute adrenal crisis grew, the Endocrine Society in 2016 and the European Society of Endocrinology in 2019 each published or updated clinical practice guidelines on adrenal insufficiency and acute adrenal crisis. These guidelines systematized patient education, stress-dose protocols, and emergency treatment algorithms, and have since been used as standard reference guidelines in endocrinology clinical practice worldwide.
Addisonian crisis (acute adrenal crisis) occurs when the cortisol supply fails to meet requirements. It can be divided into two main mechanisms.
Mechanism 1: Stress-induced crisis in patients with underlying adrenal insufficiency
It occurs when physical stress causes cortisol requirements to exceed supply in patients who already have primary (E27.1), secondary (pituitary cause), or tertiary (hypothalamic cause) adrenal insufficiency. Main precipitating factors:
Mechanism 2: First presentation when underlying adrenal insufficiency is not known
This is the case in which a stressful situation triggers the first acute crisis in a patient with latent or undiagnosed adrenal insufficiency. Because there is no underlying diagnosis of adrenal insufficiency, the risk of delayed differential diagnosis is great, and the case fatality rate is highest.
Mechanism 3: Abrupt discontinuation of glucocorticoids
When steroids are abruptly discontinued or the dose is sharply reduced in patients who have been on long-term high-dose glucocorticoid therapy, endogenous cortisol production does not recover immediately while the hypothalamic-pituitary-adrenal axis (HPA axis) is suppressed, and an acute crisis occurs. Recovery of the HPA axis after steroid discontinuation may take several months.
Mechanism 4: Acute destruction of the adrenal glands themselves
These include bilateral adrenal hemorrhagic infarction in meningococcal sepsis (Waterhouse-Friderichsen syndrome), adrenal hemorrhage during anticoagulant therapy, adrenal infarction in antiphospholipid antibody syndrome, and rapid adrenal destruction by metastatic cancer.
Addisonian crisis (acute adrenal crisis) itself is not a genetic disease directly caused by an independent gene abnormality. However, the diseases causing the underlying adrenal insufficiency that precipitates crisis have various genetic bases, and this genetic background determines vulnerability to acute crisis.
Genetic background of autoimmune adrenal insufficiency (E27.1)
As described above in the E27.1 (Addison disease) section, polygenic genetic factors such as HLA-DR3/DR4, CTLA-4, and PTPN22 determine vulnerability to autoimmune adrenal insufficiency. When individuals carrying these gene variants progress to autoimmune adrenal insufficiency, they are exposed to the risk of adrenal crisis.
Crisis risk in monogenic adrenal insufficiency
Genetic irrelevance of secondary adrenal insufficiency (related to glucocorticoid treatment)
Secondary adrenal insufficiency and acute crisis due to long-term glucocorticoid therapy are fundamentally drug adverse effects and have no genetic cause. However, there may be individual differences in glucocorticoid sensitivity and the degree of HPA axis suppression, and some studies suggest that genetic factors may be partly involved in this.
In all patients clinically at risk of adrenal crisis, identifying the cause and genetic background of the underlying adrenal insufficiency is important for long-term management planning and family genetic counseling.
The epidemiology of Addisonian crisis (acute adrenal crisis) is understood through studies based on populations of patients with underlying adrenal insufficiency. Acute adrenal crisis is a not uncommon endocrine emergency.
Incidence
The incidence of acute adrenal crisis in patients with adrenal insufficiency is reported to be about 8~14/100 patient-years. In a large German cohort study (Hahner et al., 2010), the annual incidence of adrenal crisis in patients with primary adrenal insufficiency was about 8.3/100 patient-years. About half of these are severe crises requiring hospitalization, and fatal crises are estimated at about 0.5/100 patient-years.
Distribution of main precipitating factors
Infection (gastrointestinal, respiratory, urinary tract infection, etc.) is the most common precipitating factor, accounting for about 30~40%, followed by failure to give a stress dose/medication failure in stressful situations (about 25%), unknown causes (about 20%), poor drug absorption due to nausea and vomiting (about 15%), with surgery and procedure-related causes accounting for the remainder.
Sex and age distribution
Because underlying autoimmune adrenal insufficiency is more common in women, adrenal crisis also tends to occur more often in women. However, a first crisis in undiagnosed adrenal insufficiency or a crisis in pediatric CAH occurs regardless of sex or age.
The problem of diagnostic delay
One of the most serious epidemiological problems of adrenal crisis is when it occurs in patients whose underlying adrenal insufficiency is not known. In such cases, if patients presenting to the emergency department with abdominal pain, hypotension, and nausea and vomiting are mistaken for various other diagnoses (acute abdomen, septic shock, etc.) and appropriate corticosteroid administration is delayed, the risk of death rises sharply. In literature reports, diagnostic delay and treatment delay were contributing factors in a considerable number of patients who died of adrenal crisis.
Epidemiology in Korea
Independent epidemiological data on acute adrenal crisis in Korea are limited. However, use of the E27.2 code is observed in endocrine emergency databases and health insurance claims data, and adrenal crisis is an important clinical situation continually addressed in Korean emergency medicine and endocrine practice.
The core pathophysiology of Addisonian crisis is a state in which hypofunctioning adrenal glands cannot supply sufficient cortisol relative to a stress-induced surge in cortisol requirements. This imbalance produces complex catastrophic consequences in the systemic circulation, metabolism, and electrolytes.
Normal stress response of cortisol
Under normal conditions, when physical stress (infection, surgery, trauma, etc.) occurs, the HPA axis is activated and cortisol secretion increases to 5~10 times baseline within minutes to tens of minutes. In this situation, cortisol helps the body overcome stress through various mechanisms: ① maintaining blood glucose by increasing gluconeogenesis, ② enhancing the vasoconstrictor response to catecholamines (permissive effect), ③ regulating the inflammatory response, ④ coordinating the immune response, and ⑤ maintaining fluid and electrolyte balance.
Failure of the stress response in adrenal insufficiency
When stress is applied in patients with adrenal insufficiency, cortisol secretion does not increase and remains at an already low level or decreases further. As a result, the following cascade of abnormalities occurs.
These complex abnormalities progress rapidly within hours and, without treatment, lead to irreversible shock, multiorgan failure, and death. Conversely, the fact that this cascade can be rapidly reversed by immediate hydrocortisone administration and fluid replacement explains the dramatic effect of treatment for Addisonian crisis.
The symptoms of Addisonian crisis are divided into a prodromal stage and an acute phase, and the presentation may differ somewhat depending on the type of underlying adrenal insufficiency (primary vs. secondary) and the precipitating factor.
Prodromal symptoms (hours to days before)
In patients with underlying adrenal insufficiency, the following prodromal symptoms appear after exposure to a precipitating factor, and progression to crisis can be prevented by giving a stress dose during this period.
Acute-phase symptoms
Differences in secondary and tertiary adrenal insufficiency
In secondary (pituitary) and tertiary (hypothalamic) adrenal insufficiency, aldosterone secretion is relatively preserved, so hyponatremia is mainly due to ADH abnormality (excess water retention) caused by cortisol deficiency. Therefore, hyperkalemia is often not as severe as in primary adrenal insufficiency. In addition, there is no skin hyperpigmentation, and other anterior pituitary hormone deficiencies (hypothyroidism, hypogonadism, etc.) may accompany.
The objective signs seen in Addisonian crisis are important for immediate clinical suspicion and treatment decisions.
Vital sign abnormalities
Biochemical findings
Imaging findings
Screening for prevention of Addisonian crisis is part of a systematic management program for patients with underlying adrenal insufficiency.
Monitoring for crisis signs in patients with underlying adrenal insufficiency
In patients diagnosed with adrenal insufficiency (E27.1, CAH, etc.), the following items are evaluated at regular outpatient visits to identify crisis risk proactively.
Screening in the emergency setting
In emergency department or hospitalized patients, the possibility of adrenal crisis is promptly considered when the following conditions are met.
Importance of blood sampling before treatment
When there is clinical suspicion, blood is drawn before starting treatment to test cortisol, ACTH, electrolytes, and blood glucose. However, treatment must not be delayed while waiting for test results. When adrenal crisis is strongly suspected clinically, hydrocortisone is given immediately, and the test results are used later to confirm the diagnosis.
The diagnosis of Addisonian crisis is made by a combination of clinical symptoms and biochemical findings, and prioritizing treatment over diagnosis is the core principle.
Diagnostic criteria
There is no established single diagnostic criterion for acute adrenal crisis, but in clinical practice a clinical diagnosis is made when the following conditions are met.
Essential emergency tests
Differential diagnosis
Addisonian crisis is an endocrine emergency in which immediate management determines survival. The three pillars of treatment are ① immediate corticosteroid administration, ② fluid replacement, and ③ treatment of the precipitating cause.
Immediate management — in the emergency department or immediately on arrival
Maintenance treatment — the following 24~48 hours
Treatment of the precipitating cause
Dose tapering and return to maintenance dose
Once clinically recovered (usually within 24~48 hours), hydrocortisone is gradually reduced. When oral intake becomes possible after the crisis resolves, it is switched to the baseline maintenance dose (usually 15~25 mg/day), and the dose is kept doubled until the causative infection or other trigger has completely resolved, then normalized. Fludrocortisone can be temporarily stopped when hydrocortisone is ≥50 mg/day (hydrocortisone itself has mineralocorticoid activity) and is restarted when hydrocortisone is reduced below 50 mg/day.
The prognosis of Addisonian crisis is critically determined by the speed of diagnosis and treatment.
Prognosis with early recognition and immediate treatment
With appropriate hydrocortisone administration and fluid replacement, most patients show dramatic clinical improvement within hours. Hypotension begins to recover within 1–4 hours, followed by improved consciousness and resolution of nausea and abdominal pain. With early treatment, complete recovery is possible, and patients return to baseline maintenance therapy without sequelae.
Consequences of delayed treatment
If treatment is delayed by more than several hours, it leads to irreversible shock, multiorgan failure, brain damage, and death. Deaths related to adrenal crisis still occur today, and most are attributable to preventable factors such as delayed diagnosis, failure to apply stress dosing, and not carrying emergency injectables.
Recurrence risk and long-term prognosis
Adrenal crisis carries a high risk of recurrence. Patients who have experienced a first crisis are likely to have a recurrence in the same circumstances, so patient education must be thoroughly reinforced after the crisis. Correct implementation of the stress-dose protocol when precipitating factors (infection, surgery, stress) occur is key to preventing recurrence. In the long term, with continuous hormone replacement therapy for the underlying adrenal insufficiency and regular follow-up, normal life expectancy and quality of life can be maintained.
Prognosis in special situations
Addisonian crisis is an emergency that is largely preventable with proper education and protocol adherence. Prevention rests on three pillars: patient education, healthcare provider education, and the healthcare system level.
Patient and caregiver education — the core of primary prevention
Every patient diagnosed with adrenal insufficiency (or their caregiver) must be fully familiar with the following.
Preoperative steroid coverage protocol
When surgery or an invasive procedure is planned, the anesthesiologist and surgeon must be informed of the adrenal insufficiency, and an appropriate steroid coverage protocol according to the extent of surgery (minor surgery: hydrocortisone 25–50 mg once; major surgery: 100 mg at induction + intravenous maintenance during and after surgery) is agreed upon in advance and implemented.
Education for healthcare providers
All healthcare providers who handle emergency patients, including those in emergency medicine, internal medicine, surgery, and pediatrics, must recognize the clinical presentation of acute adrenal crisis and know the principle of administering hydrocortisone immediately when it is suspected. Awareness is needed that "in a patient with shock of unknown cause, hydrocortisone administration is harmless and can save lives."
Prevention at the healthcare system level
Clearly document adrenal insufficiency or steroid dependence in the medical record and activate alert functions in the electronic medical record. Standardize in-hospital emergency management guidelines for adrenal insufficiency and build a system that checks this item at emergency department triage.
Rushworth RL, Torpy DJ, Falhammar H. Adrenal crisis. New England Journal of Medicine. 2019;381(9):852–861. DOI: 10.1056/NEJMra1807486. PMID: 31461595.
Hahner S, Loeffler M, Bleicken B, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. European Journal of Endocrinology. 2010;162(3):597–602. DOI: 10.1530/EJE-09-0876. PMID: 20022946.
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2016;101(2):364–389. DOI: 10.1210/jc.2015-1710. PMID: 26760044.
Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613–629. DOI: 10.1016/S0140-6736(21)00136-7. PMID: 33484633.
Arlt W; Society for Endocrinology Clinical Committee. Society for Endocrinology Endocrine Emergency Guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocrine Connections. 2016;5(5):G1–G3. DOI: 10.1530/EC-16-0054. PMID: 27942635.
Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes & Endocrinology. 2015;3(3):216–226. DOI: 10.1016/S2213-8587(14)70142-1. PMID: 25098712.
Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal crisis: still a deadly event in the 21st century. American Journal of Medicine. 2016;129(3):339.e1–339.e9. DOI: 10.1016/j.amjmed.2015.08.021. PMID: 26363354.
Allolio B. Extensive expertise in endocrinology: adrenal crisis. European Journal of Endocrinology. 2015;172(3):R115–R124. DOI: 10.1530/EJE-14-0824. PMID: 25288674.
Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75(5):654–663. DOI: 10.1111/anae.14963. PMID: 32017028.
Reisch N, Arlt W, Krone N. Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research in Paediatrics. 2011;76(2):73–85. DOI: 10.1159/000327794. PMID: 21757924.